Fabio
3.3 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Relates to prescription labels for mifepristone and misoprostol | Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol. | us/states/ny | New York Legislature | 2025-2026 | A 5285 | New York A 5285 (2025-2026) |
|
enacted |
|
1 | 14 | 2 | 2025-02-12 | 2025-03-20 | openstates | ocd-bill/789318fc-aecc-475d-85cb-d307ae93d41f | http://www.nysenate.gov/legislation/bills/2025/A5285 | f6a85b31b58e1691a13106c8999427b4fb63b2353e916f475b1a8a5b4fea97dd | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
New York A 5285 (2025-2026) — Relates to prescription labels for mifepristone and misoprostol
Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- A5285 (committee substitute) — source
Votes
- Floor Vote — 40–21 (pass) · upper
- Assembly Vote — 96–51 (pass) · lower
Sponsors
- Karines Reyes — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2025-02-12 REFERRED TO HIGHER EDUCATION
referral-committee - 2025-02-24 REPORTED REFERRED TO RULES
referral-committee - 2025-02-25 REPORTED
- 2025-02-25 RULES REPORT CAL.103
- 2025-02-25 ORDERED TO THIRD READING RULES CAL.103
- 2025-03-05 PASSED ASSEMBLY
passage - 2025-03-05 DELIVERED TO SENATE
- 2025-03-05 REFERRED TO RULES
referral-committee - 2025-03-10 SUBSTITUTED FOR S4587
- 2025-03-10 3RD READING CAL.447
- 2025-03-10 PASSED SENATE
passage - 2025-03-10 RETURNED TO ASSEMBLY
- 2025-03-20 DELIVERED TO GOVERNOR
executive-receipt - 2025-03-20 SIGNED CHAP.108
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/789318fc-aecc-475d-85cb-d307ae93d41f. Confidence: reported (aggregated from official New York legislature records).